Skip to content

Pomona II (2005-2008) Health Indicators for People with Intellectual Disabilities: Using an Indicator Set

Pomona II (2005-2008) Health Indicators for People with Intellectual Disabilities: Using an Indicator Set - Pomona II

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON30156
Enrollment
80
Registered
2006-06-30
Start date
2006-07-01
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

zorggebruik health indicators

Interventions

None listed

Sponsors

Europese Commissie; DG Public Health; Health & Consumer Protection
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 50% of the adults with Intellectual Disabilities (ID) are living with their families and 50% are living in residential facilities. ;The people with ID living with their family, and living in residential facilities are clustered according to age: 18-34, 35-54, 55 and older. Within this list for each agegroup the same number of persons are included. ;About 40% of the total group of adults with ID living with their families and 40% of the total group of people with ID living in residential facilities should be diagnosed as having severe or profound ID.

Exclusion criteria

Exclusion criteria: younger than 18 years

Design outcomes

Secondary

MeasureTime frame
The results will be used to develop teaching materials and recommendations for teaching on health of people with ID, throughout the Member States. Project activities and findings will be disseminated throughout Member State, European and international levels through reports, scientific publications, presentations at (inter) national meetings. This will include user-friendly versions.

Primary

MeasureTime frame
Information on health and health care use in people with ID in the participating countries. Feasibility of the indicator set, which may be developed further for research and planning purposes.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)